Budesonide Capsule, Coated Pellets
Product Images NDC 16714-829

2 FDA label images from Northstar Rx Llc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 16714-829). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Budesonide (1780fdb2 9492 4cec 840e 923f19561188 01)

Budesonide (1780fdb2 9492 4cec 840e 923f19561188 01)
Chemical structure diagram showing the epimers 22R and 22S of budesonide, a corticosteroid active ingredient. The structures illustrate molecular connectivity and stereochemistry relevant to the two epimeric forms of budesonide.*
FDA Label Image

Budesonide Capsules Label (1780fdb2 9492 4cec 840e 923f19561188 02)

Budesonide Capsules Label (1780fdb2 9492 4cec 840e 923f19561188 02)
Label for Budesonide Delayed-Release Capsules, 3 mg strength, oral dosage form, containing 100 capsules. The label indicates prescription use only (Rx only) and includes storage instructions (20°C to 25°C), dosage directions, and safety warnings. Manufactured by Zydus Lifesciences Ltd. for Northstar Rx LLC, Memphis, TN. Product of India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.